Cargando…

Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility

The prevalence of antifungal resistance in Candida glabrata, especially against azole drugs, results in difficult-to-treat and potentially life-threatening infections. Understanding the molecular basis of azole resistance in C. glabrata is crucial to designing more suitable therapeutic strategies. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pais, Pedro, Galocha, Mónica, Califórnia, Raquel, Viana, Romeu, Ola, Mihaela, Okamoto, Michiyo, Chibana, Hiroji, Butler, Geraldine, Teixeira, Miguel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779156/ https://www.ncbi.nlm.nih.gov/pubmed/35050001 http://dx.doi.org/10.3390/jof8010061

Ejemplares similares

Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability
por: Pais, Pedro, et al.
Publicado: (2020)

A new regulator in the crossroads of oxidative stress resistance and virulence in Candida glabrata: The transcription factor CgTog1
por: Pais, Pedro, et al.
Publicado: (2020)

Membrane Proteomics Analysis of the Candida glabrata Response to 5-Flucytosine: Unveiling the Role and Regulation of the Drug Efflux Transporters CgFlr1 and CgFlr2
por: Pais, Pedro, et al.
Publicado: (2016)

Genomic evolution towards azole resistance in Candida glabrata clinical isolates unveils the importance of CgHxt4/6/7 in azole accumulation
por: Galocha, Mónica, et al.
Publicado: (2022)

Role of CgTpo4 in Polyamine and Antimicrobial Peptide Resistance: Determining Virulence in Candida glabrata
por: Cavalheiro, Mafalda, et al.
Publicado: (2021)

From the first touch to biofilm establishment by the human pathogen Candida glabrata: a genome-wide to nanoscale view
por: Cavalheiro, Mafalda, et al.
Publicado: (2021)

In Candida glabrata, ERMES Component GEM1 Controls Mitochondrial Morphology, mtROS, and Drug Efflux Pump Expression, Resulting in Azole Susceptibility
por: Okamoto, Michiyo, et al.
Publicado: (2023)

The CgHaa1-Regulon Mediates Response and Tolerance to Acetic Acid Stress in the Human Pathogen Candida glabrata
por: Bernardo, Ruben T., et al.
Publicado: (2016)

Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants
por: Pais, Pedro, et al.
Publicado: (2022)

A New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1
por: Romão, Daniela, et al.
Publicado: (2017)

Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019)

Screening the Drug:H(+) Antiporter Family for a Role in Biofilm Formation in Candida glabrata
por: Santos, Rui, et al.
Publicado: (2020)

Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata
por: Ferrari, Sélène, et al.
Publicado: (2011)

Evaluation of Antifungal Selective Toxicity Using Candida glabrata ERG25 and Human SC4MOL Knock-In Strains
por: Nakano, Keiko, et al.
Publicado: (2023)

The dual role of candida glabrata drug:H+ antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance
por: Costa, Catarina, et al.
Publicado: (2013)

Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata
por: Kumari, Sonam, et al.
Publicado: (2022)

Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin
por: Galocha, Mónica, et al.
Publicado: (2019)

KRE5 Suppression Induces Cell Wall Stress and Alternative ER Stress Response Required for Maintaining Cell Wall Integrity in Candida glabrata
por: Tanaka, Yutaka, et al.
Publicado: (2016)

A Transcriptomics Approach To Unveiling the Mechanisms of In Vitro Evolution towards Fluconazole Resistance of a Candida glabrata Clinical Isolate
por: Cavalheiro, Mafalda, et al.
Publicado: (2018)

The Lack of SNARE Protein Homolog Syn8 Influences Biofilm Formation of Candida glabrata
por: Chen, Xinyue, et al.
Publicado: (2021)

Draft Genome Sequences of Three Clinical Isolates of the Pathogenic Yeast Candida glabrata
por: Pais, Pedro, et al.
Publicado: (2019)

Effects of Aspirin as an Anti-inflammatory Drug on Azole-resistant Candida glabrata In Vitro
por: GOODARZI, Sanaz, et al.
Publicado: (2016)

Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species
por: Nagayoshi, Yohsuke, et al.
Publicado: (2017)

Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?
por: Wilson, Aze, et al.
Publicado: (2014)

Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China
por: Yao, Dongting, et al.
Publicado: (2019)

Disclosing azole resistance mechanisms in resistant Candida glabrata strains encoding wild-type or gain-of-function CgPDR1 alleles through comparative genomics and transcriptomics
por: Salazar, Sara B, et al.
Publicado: (2022)

Erg25 Controls Host-Cholesterol Uptake Mediated by Aus1p-Associated Sterol-Rich Membrane Domains in Candida glabrata
por: Okamoto, Michiyo, et al.
Publicado: (2022)

Intestinal Resident Yeast Candida glabrata Requires Cyb2p-Mediated Lactate Assimilation to Adapt in Mouse Intestine
por: Ueno, Keigo, et al.
Publicado: (2011)

CgSTE11 mediates cross tolerance to multiple environmental stressors in Candida glabrata
por: Huang, Mian, et al.
Publicado: (2019)

High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran
por: Zarrinfar, Hossein, et al.
Publicado: (2021)

Tup1 Paralog CgTUP11 Is a Stronger Repressor of Transcription than CgTUP1 in Candida glabrata
por: Bui, Lilian N., et al.
Publicado: (2022)

Effect of Acetic Acid and Lactic Acid at Low pH in Growth and Azole Resistance of Candida albicans and Candida glabrata
por: Lourenço, Andreia, et al.
Publicado: (2019)

The secreted acid trehalase encoded by the CgATH1 gene is involved in Candida glabrata virulence
por: Lopes, Rafael G, et al.
Publicado: (2020)

New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae
por: Costa, Catarina, et al.
Publicado: (2015)

Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment
por: Li, Qingdi Quentin, et al.
Publicado: (2012)

Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates
por: Denardi, Laura Bedin, et al.
Publicado: (2015)

Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP
por: Farahyar, Shirin, et al.
Publicado: (2013)

Inositol Phosphoryl Transferase, Ipt1, Is a Critical Determinant of Azole Resistance and Virulence Phenotypes in Candida glabrata
por: Shahi, Garima, et al.
Publicado: (2022)

Elucidating the Eradication Mechanism of Perillyl Alcohol against Candida glabrata Biofilms: Insights into the Synergistic Effect with Azole Drugs
por: Gupta, Payal, et al.
Publicado: (2021)

Clotrimazole Drug Resistance in Candida glabrata Clinical Isolates Correlates with Increased Expression of the Drug:H(+) Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2
por: Costa, Catarina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dmuhgo7m5bl9800gcoek17u7f1